These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 19139770)
1. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line. Yang JX; Luo Y; Qiu HM; Tang WX Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770 [TBL] [Abstract][Full Text] [Related]
2. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics]. Yang JX; Tang WX Ai Zheng; 2002 Aug; 21(8):872-6. PubMed ID: 12478896 [TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer. Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380 [TBL] [Abstract][Full Text] [Related]
4. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme. Wang W; Liu G; Zheng J Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556 [TBL] [Abstract][Full Text] [Related]
5. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP]. Zhou XJ; Li Q; Chen WT Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583 [TBL] [Abstract][Full Text] [Related]
6. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616 [TBL] [Abstract][Full Text] [Related]
7. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Zhou J; Cheng SC; Luo D; Xie Y Biochem Biophys Res Commun; 2001 Feb; 280(5):1237-42. PubMed ID: 11162660 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826 [TBL] [Abstract][Full Text] [Related]
9. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance. Beketić-Oresković L; Osmak M; Jaksić M Neoplasma; 1994; 41(3):163-9. PubMed ID: 7935985 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids. Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Saburi Y; Nakagawa M; Ono M; Sakai M; Muramatsu M; Kohno K; Kuwano M Cancer Res; 1989 Dec; 49(24 Pt 1):7020-5. PubMed ID: 2479474 [TBL] [Abstract][Full Text] [Related]
12. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations. Yan XD; Li M; Yuan Y; Mao N; Pan LY Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060 [TBL] [Abstract][Full Text] [Related]
13. [Establishment and biological characteristics of cisplatin resistant cell line from human tongue squamous cell carcinoma Tca8113]. Zhou XJ; Chen WT; Li Q; He RG Shanghai Kou Qiang Yi Xue; 2001 Mar; 10(1):31-4. PubMed ID: 14994074 [TBL] [Abstract][Full Text] [Related]
14. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL; Hwang J; Perng RP; Whang-Peng J Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042 [TBL] [Abstract][Full Text] [Related]
15. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells. Ekblad L; Kjellström J; Johnsson A Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208 [TBL] [Abstract][Full Text] [Related]
16. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles. Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547 [TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP. Zhan M; Liu X Chin Med J (Engl); 1999 Apr; 112(4):336-9. PubMed ID: 11593534 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate. Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724 [TBL] [Abstract][Full Text] [Related]
20. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics]. Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]